News Sanofi to pay back Philippines after Dengue vaccine problems Sanofi’s is to pay back money to the Philippines government for unused doses of its Dengue fever vaccine, after serious safety concerns halted its use.
News Lilly to research real world diabetes with digital health fi... Eli Lilly and digital health firm Livongo are to collaborate on real-world studies and develop new insights into diabetes.
News Sanofi's Dengue vaccine launch turns into nightmare Philippines halts vaccination programme on safety issues
US Sanofi turns the tables on Lilly with biosimilar fast-acting... Big-selling Humalog facing cut price competition
News Dance Biopharm to develop inhaled insulin with Phillips-Medi... Biotech working on soft mist insulin delivery device with IT firm
News Court sides with EU on decision to revoke Ocaliva's license Advanz Pharma's bid to keep its Ocaliva treatment for rare liver disease primary biliary cholangitis (PBC) on the EU market has ended in failure
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends